**Kura Oncology Announces Chief Medical Officer Resignation and New Appointments**SAN DIEGO, Calif.–(BUSINESS WIRE)–January 6, 2025Kura Oncology, Inc. (NASDAQ:KURA) recently disclosed in an 8-K filing a significant change in its executive leadershi
* This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Kura Oncology’s 8K filing here. Kura Oncology Company Profile (Get Free Report) Kura Oncology, Inc, a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company’s pipeline consists of […]
More Stories
Cantor Fitzgerald Reiterates Overweight Rating for Rivian Automotive (NASDAQ:RIVN)
Rivian Automotive (NASDAQ:RIVN – Get Free Report)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a report issued...
The Goldman Sachs Group Initiates Coverage on ServiceTitan (NASDAQ:TTAN)
Stock analysts at The Goldman Sachs Group assumed coverage on shares of ServiceTitan (NASDAQ:TTAN – Get Free Report) in a...
Oppenheimer Raises Atlassian (NASDAQ:TEAM) Price Target to $300.00
Atlassian (NASDAQ:TEAM – Get Free Report) had its target price lifted by equities researchers at Oppenheimer from $270.00 to $300.00...
Truist Financial Issues Pessimistic Forecast for PotlatchDeltic (NASDAQ:PCH) Stock Price
PotlatchDeltic (NASDAQ:PCH – Get Free Report) had its price target cut by Truist Financial from $45.00 to $44.00 in a...
Argus Forecasts Strong Price Appreciation for Netflix (NASDAQ:NFLX) Stock
Netflix (NASDAQ:NFLX – Get Free Report) had its target price raised by investment analysts at Argus from $840.00 to $1,040.00...
MongoDB (NASDAQ:MDB) Upgraded to “Buy” at Guggenheim
MongoDB (NASDAQ:MDB – Get Free Report) was upgraded by Guggenheim from a “neutral” rating to a “buy” rating in a...